<DOC>
	<DOCNO>NCT00548717</DOCNO>
	<brief_summary>This trial test hypothesis combination sirolimus , mycophenolate mofetil , bortezomib effective prevent acute chronic GVHD reduce intensity allogeneic stem cell transplantation .</brief_summary>
	<brief_title>Sirolimus , Mycophenolate Mofetil Bortezomib Graft-Versus-Host Disease ( GVHD ) Prophylaxis After Reduced Intensity Conditioning ( RIC ) Hematopoietic Stem Cell Transplantation</brief_title>
	<detailed_description>The combination tacrolimus methotrexate standard therapy prevention GVHD , however , recent experience demonstrate substitution sirolimus methotrexate provide superior GVHD control reduce transplant-related toxicity . One limitation use calcineurin inhibitor GVHD prevention disruption Treg function proliferation . Based evolve understanding role Treg development chronic GVHD , propose GVHD prophylactic regimen effective prevention acute GVHD , virtue maintenance Treg activity may able prevent chronic GVHD . We hypothesize substitution mycophenolate mofetil tacrolimus well addition bortezomib may provide similar protection acute GVHD prevent chronic GVHD minimize renal toxicity transplantation .</detailed_description>
	<mesh_term>Graft v Host Disease</mesh_term>
	<mesh_term>Bortezomib</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<criteria>1 . Patients hematologic malignancy , high risk complication conventional myeloablative transplantation 2 . Patients must 6/6 matched , relate donor . Matching HLA Class II base PCR sequence specific primer ( SSP ) . Among family member transplant , serologic match Class I sufficient 3 . Patient age great 18 4 . Performance status 02 5 . Life expectancy &gt; 100 day without transplantation 6 . Written informed consent must obtain case patient 1 . Pregnancy 2 . Prior Allogeneic Stem Cell Transplantation donor 3 . Evidence HIV infection active Hepatitis B C infection 4 . Heart failure uncontrolled medication 5 . Total bilirubin &gt; 2.0 mg/dl due hepatocellular dysfunction 6 . AST &gt; 90 7 . Cholesterol &gt; 300 mg/dl Triglycerides &gt; 400 mg/dl adequately treat 8 . Uncontrolled bacterial , viral fungal infection 9 . Requirement voriconazole time hospital admission</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>GVHD</keyword>
	<keyword>Stem cell transplantation</keyword>
	<keyword>Sirolimus</keyword>
</DOC>